Safety of Boniva IV
Osteoporosis is a disease that gradually causes the bones to lose mass over time. Fortunately, there are some medical options for those affected by osteoporosis. Among these is Boniva IV.
Other People Are Reading
-
Identification
-
Boniva IV is an intravenous medication. Unlike similar medications that are used monthly in pill form, nurses administer Boniva IV (ibandronate sodium) to patients every three months via injection, according to Drugs.com.
Features
-
Boniva IV is classified as a bisphosphonate. According to the U.S. National Library of Medicine, bisphosphonate works by preventing existing bone from breaking down while assisting the rebuilding of bone density.
-
Safety
-
Boniva IV may not be safe for patients who have uncorrected hypocalcemia, or low blood calcium levels. According to Drugs.com, intravenous Boniva may further lower calcium levels. Because Boniva IV may cause jaw problems, the U.S. National Library of Medicines cautions against using it if you plan to receive dental treatment or surgery.
Side Effects
-
According to the National Library of Medicine, side effects of Boniva IV include stomach pain, diarrhea, constipation, back pain, rash, leg pain, headaches, painful urination or swelling around the site of the injection. Serious side effects include swollen gums, numbness in the jaw, eye pain and sensitivity to light. Contact a health-care provider if you have serious side effects or if regular side effects do not ease over time.
-
References
Resources
- Photo Credit needle image by Marek Kosmal from Fotolia.com
